Transplant Medicine

'Killer' cells used to combat rare cancer

Published in Blood Weekly, October 31st, 2002

Scientists from the University of Edinburgh are using immune cells harvested from blood donors to help fight an unusual cancer that can affect transplant patients.

And their findings, published recently in the Lancet show that the therapy has proved effective in a number of cases. The treatment proved successful last year in saving the life of a 4-year-old boy from Birmingham, who developed the cancer- post-transplant lymphoproliferative disease - following a liver and bowel transplant.

The technique, which involves boosting the patient's own immune system to fight cancer without affecting the transplanted organ, can also be adapted to treat...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2002-10-31)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry